These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 29414639)

  • 21. Caffeic acid prevents acetaminophen-induced liver injury by activating the Keap1-Nrf2 antioxidative defense system.
    Pang C; Zheng Z; Shi L; Sheng Y; Wei H; Wang Z; Ji L
    Free Radic Biol Med; 2016 Feb; 91():236-46. PubMed ID: 26721592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The hepatoprotective effect of myricetin against lipopolysaccharide and D-galactosamine-induced fulminant hepatitis.
    Lv H; An B; Yu Q; Cao Y; Liu Y; Li S
    Int J Biol Macromol; 2020 Jul; 155():1092-1104. PubMed ID: 31712142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atractylodin ameliorates lipopolysaccharide and d-galactosamine-induced acute liver failure via the suppression of inflammation and oxidative stress.
    Lyu Z; Ji X; Chen G; An B
    Int Immunopharmacol; 2019 Jul; 72():348-357. PubMed ID: 31030090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amygdalin attenuates acute liver injury induced by D-galactosamine and lipopolysaccharide by regulating the NLRP3, NF-κB and Nrf2/NQO1 signalling pathways.
    Tang F; Fan K; Wang K; Bian C
    Biomed Pharmacother; 2019 Mar; 111():527-536. PubMed ID: 30597306
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rosmarinic acid protects mice from lipopolysaccharide/d-galactosamine-induced acute liver injury by inhibiting MAPKs/NF-κB and activating Nrf2/HO-1 signaling pathways.
    Li Z; Feng H; Wang Y; Shen B; Tian Y; Wu L; Zhang Q; Jin M; Liu G
    Int Immunopharmacol; 2019 Feb; 67():465-472. PubMed ID: 30597292
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Panaxynol from
    Sun X; Zhang T; Zhao Y; Cai E; Zhu H; Liu S
    Biotech Histochem; 2020 Nov; 95(8):575-583. PubMed ID: 32295432
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protective effect of oroxylin A against lipopolysaccharide and/or D-galactosamine-induced acute liver injury in mice.
    Huang H; Zhang X; Li J
    J Surg Res; 2015 May; 195(2):522-8. PubMed ID: 25818981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The involvement of Nrf2 in the protective effects of diallyl disulfide on carbon tetrachloride-induced hepatic oxidative damage and inflammatory response in rats.
    Lee IC; Kim SH; Baek HS; Moon C; Kang SS; Kim SH; Kim YB; Shin IS; Kim JC
    Food Chem Toxicol; 2014 Jan; 63():174-85. PubMed ID: 24246655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nobiletin attenuates lipopolysaccharide/D‑galactosamine‑induced liver injury in mice by activating the Nrf2 antioxidant pathway and subsequently inhibiting NF‑κB‑mediated cytokine production.
    He Z; Li X; Chen H; He K; Liu Y; Gong J; Gong J
    Mol Med Rep; 2016 Dec; 14(6):5595-5600. PubMed ID: 27878238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dietary luteolin attenuates chronic liver injury induced by mercuric chloride via the Nrf2/NF-κB/P53 signaling pathway in rats.
    Zhang H; Tan X; Yang D; Lu J; Liu B; Baiyun R; Zhang Z
    Oncotarget; 2017 Jun; 8(25):40982-40993. PubMed ID: 28498799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pretreatment of lipopolysaccharide (LPS) ameliorates D-GalN/LPS induced acute liver failure through TLR4 signaling pathway.
    Zhang S; Yang N; Ni S; Li W; Xu L; Dong P; Lu M
    Int J Clin Exp Pathol; 2014; 7(10):6626-34. PubMed ID: 25400741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatoprotective effect of cryptotanshinone from Salvia miltiorrhiza in D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure.
    Jin Q; Jiang S; Wu YL; Bai T; Yang Y; Jin X; Lian LH; Nan JX
    Phytomedicine; 2014 Jan; 21(2):141-7. PubMed ID: 24011530
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Maslinic acid protects against lipopolysaccharide/d-galactosamine-induced acute liver injury in mice.
    Wang YY; Diao BZ; Zhong LH; Lu BL; Cheng Y; Yu L; Zhu LY
    Microb Pathog; 2018 Jun; 119():49-53. PubMed ID: 29627448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Maresin 1 protects against lipopolysaccharide/d-galactosamine-induced acute liver injury by inhibiting macrophage pyroptosis and inflammatory response.
    Yang W; Tao K; Zhang P; Chen X; Sun X; Li R
    Biochem Pharmacol; 2022 Jan; 195():114863. PubMed ID: 34861244
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mangiferin Attenuates LPS/D-GalN-Induced Acute Liver Injury by Promoting HO-1 in Kupffer Cells.
    Yang S; Kuang G; Zhang L; Wu S; Zhao Z; Wang B; Yin X; Gong X; Wan J
    Front Immunol; 2020; 11():285. PubMed ID: 32158448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ethanol extracts of Rhaponticum uniflorum (L.) DC inflorescence ameliorate LPS-mediated acute lung injury by alleviating inflammatory responses via the Nrf2/HO-1 signaling pathway.
    Zhen D; Liu C; Huang T; Fu D; Bai X; Ma Q; Jiang M; Gong G
    J Ethnopharmacol; 2022 Oct; 296():115497. PubMed ID: 35738472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatoprotective effect of quercetin against LPS/d-GalN induced acute liver injury in mice by inhibiting the IKK/NF-κB and MAPK signal pathways.
    Peng Z; Gong X; Yang Y; Huang L; Zhang Q; Zhang P; Wan R; Zhang B
    Int Immunopharmacol; 2017 Nov; 52():281-289. PubMed ID: 28963941
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protective Role of 4-Octyl Itaconate in Murine LPS/D-GalN-Induced Acute Liver Failure via Inhibiting Inflammation, Oxidative Stress, and Apoptosis.
    Li R; Yang W; Yin Y; Zhang P; Wang Y; Tao K
    Oxid Med Cell Longev; 2021; 2021():9932099. PubMed ID: 34457120
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CQMUH-011, a novel adamantane sulfonamide compound, inhibits lipopolysaccharide- and D-galactosamine-induced fulminant hepatic failure in mice.
    Yan L; Hu X; Wu Q; Jiang R; Zhang S; Ling Q; Liu H; Jiang X; Wan J; Liu Y
    Int Immunopharmacol; 2017 Jun; 47():231-243. PubMed ID: 28433945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxyresveratrol abrogates oxidative stress by activating ERK-Nrf2 pathway in the liver.
    Choi HY; Lee JH; Jegal KH; Cho IJ; Kim YW; Kim SC
    Chem Biol Interact; 2016 Feb; 245():110-21. PubMed ID: 26102008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.